FDA Supports DSS in Suspending Sowore's Prosecution
The Foundation for Democracy in Africa (FDA) has endorsed the decision by the Director-General of the Department of State Services (DSS), Oluwatosin Adeola Ajayi, to suspend the criminal prosecution of Sowore, the presidential candidate of the African Action Congress (AAC), until after the 2027 presidential election. The FDA views this move as a commitment to democracy, due process, and the integrity of the electoral process.
They argue that no presidential candidate should face disadvantages from pending criminal proceedings during an election period, aligning with various regional and international democratic frameworks. The FDA also commended Ajayi for his broader commitment to due process since his appointment in August 2024, citing actions such as the release of wrongfully detained individuals and compensation payments.
They clarified that suspending the prosecution does not terminate the case, allowing for court proceedings to resume after the elections in accordance with due process.
Plus234Feed summary based on reporting from Legit.ng. Read the original report below.
Read full article
Continue on Legit.ng
Enjoy this article?
Get the weekly Nigerian roundup — top stories, NPFL, naira. One email, Sunday morning.
Related Stories
FDA Backs DSS Decision to Pause Sowore's Prosecution
AAC Rejects Suspension of Sowore's Trial Until 2027
Sowore Demands DSS Apology Over Cybercrime Trial Delay
DSS Seeks to Delay Sowore Cybercrime Trial Until After 2027 Election
SERAP Demands Withdrawal of Charges Against Sowore
DSS Seeks Adjournment in Sowore's Trial Before Elections
Get Plus234Feed on messaging apps
Same headlines, delivered where you already scroll.
